Synergy CHC Corp's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 103/158 in the Pharmaceuticals industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 7.00.In the medium term, the stock price is expected to trend down.Despite a weak stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Synergy CHC Corp's Score
Industry at a Glance
Industry Ranking
103 / 158
Overall Ranking
270 / 4582
Industry
Pharmaceuticals
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Analyst Rating
Based on
1
analysts
Buy
Current Rating
7.000
Target Price
+284.62%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Synergy CHC Corp Highlights
StrengthsRisks
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
Growing
The company is in a growing phase, with the latest annual income totaling USD 34.83M.
High Profit Growth
The company's net income leads the industry, with the latest annual income totaling USD 34.83M.
Undervalued
The company’s latest PE is 6.50, at a low 3-year percentile range.
Institutional Selling
The latest institutional holdings are 489.86K shares, decreasing 58.57% quarter-over-quarter.
Synergy CHC Corp. is a provider of consumer healthcare, beauty, and lifestyle products. The Company's brand portfolio includes FOCUSfactor and Flat Tummy. FOCUSfactor is a clinically studied brain health supplement and functional beverage line. Flat Tummy is a lifestyle brand that provides a suite of nutritional products to help women achieve their weight management goals. It has six additional, non-core brands are Hand MD is a complete hand-care brand to help maintain clean and healthy hands while reducing the signs of aging; Perfekt Beauty is in beauty line of products for the eyes, lips, brows, cheeks and skin; Sneaky Vaunt is in lingerie brand with a line of women’s shapewear, bralettes and panties; The Queen Pegasus is in eyelash enhancement products for longer, thicker, natural lashes; Neuragen is in fast-acting topical treatments for neuropathic (nerve) pain, and UrgentRx is in line of fast-acting, portable, powdered over-the-counter medications.
Ticker SymbolSNYR
CompanySynergy CHC Corp
CEORoss (Jack)
Websitehttps://synergychc.com/
FAQs
What is the current price of Synergy CHC Corp (SNYR)?
The current price of Synergy CHC Corp (SNYR) is 1.830.
What is the symbol of Synergy CHC Corp?
The ticker symbol of Synergy CHC Corp is SNYR.
What is the 52-week high of Synergy CHC Corp?
The 52-week high of Synergy CHC Corp is 5.740.
What is the 52-week low of Synergy CHC Corp?
The 52-week low of Synergy CHC Corp is 1.300.
What is the market capitalization of Synergy CHC Corp?
The market capitalization of Synergy CHC Corp is 20.59M.
What is the net income of Synergy CHC Corp?
The net income of Synergy CHC Corp is 2.12M.
Is Synergy CHC Corp (SNYR) currently rated as Buy, Hold, or Sell?
According to analysts, Synergy CHC Corp (SNYR) has an overall rating of Buy, with a price target of 7.000.
What is the Earnings Per Share (EPS TTM) of Synergy CHC Corp (SNYR)?
The Earnings Per Share (EPS TTM) of Synergy CHC Corp (SNYR) is 0.282.